Back to Search Start Over

The ideal nucleoside/nucleotide backbone

Authors :
Gallant, Joel E.
Source :
Journal of Acquired Immune Deficiency Syndromes (1999). Sept 1, 2004, Vol. 37 Issue 1, pS44, 8 p.
Publication Year :
2004

Abstract

The selection of the nucleoside/nucleotide reverse transcriptase inhibitor (NRTI/NtRTI) backbone is an important step in constructing a regimen for the treatment of HIV infection. Data published since 2000 that address NRTI/NtRTI backbone performances and safety when included in HAART regimen is reviewed.

Details

Language :
English
ISSN :
15254135
Volume :
37
Issue :
1
Database :
Gale General OneFile
Journal :
Journal of Acquired Immune Deficiency Syndromes (1999)
Publication Type :
Academic Journal
Accession number :
edsgcl.125766918